Sarae L Bausch
Examiner (ID: 5377, Phone: (571)272-2912 , Office: P/1634 )
Most Active Art Unit | 1634 |
Art Unit(s) | 1634, 1699 |
Total Applications | 913 |
Issued Applications | 172 |
Pending Applications | 136 |
Abandoned Applications | 605 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17369836
[patent_doc_number] => 20220024888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => CRYSTALLINE PPAR-DELTA AGONIST
[patent_app_type] => utility
[patent_app_number] => 17/381005
[patent_app_country] => US
[patent_app_date] => 2021-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17381005
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/381005 | Crystalline PPAR-delta agonist | Jul 19, 2021 | Issued |
Array
(
[id] => 17342127
[patent_doc_number] => 20220008458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE
[patent_app_type] => utility
[patent_app_number] => 17/365695
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365695
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/365695 | Trace element compositions, methods of making and use | Jun 30, 2021 | Issued |
Array
(
[id] => 17168759
[patent_doc_number] => 20210322429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => STABILIZED FORMULATIONS OF CNS COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/358920
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17358920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/358920 | STABILIZED FORMULATIONS OF CNS COMPOUNDS | Jun 24, 2021 | Pending |
Array
(
[id] => 19011672
[patent_doc_number] => 11918573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Ophthalmic formulations of cetirizine and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/332814
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 19581
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17332814
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/332814 | Ophthalmic formulations of cetirizine and methods of use | May 26, 2021 | Issued |
Array
(
[id] => 17095522
[patent_doc_number] => 20210283313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => HYALURONIC ACID-BASED GELS INCLUDING LIDOCAINE
[patent_app_type] => utility
[patent_app_number] => 17/331543
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17331543
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/331543 | HYALURONIC ACID-BASED GELS INCLUDING LIDOCAINE | May 25, 2021 | Pending |
Array
(
[id] => 17472522
[patent_doc_number] => 20220080026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/246086
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246086
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/246086 | FORMULATIONS | Apr 29, 2021 | Abandoned |
Array
(
[id] => 17020913
[patent_doc_number] => 20210244784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => COMPOSITION, AND METHOD OF USING THE COMPOSITION, EFFECTIVE FOR MINIMIZING THE HARMFUL EFFECTS ASSOCIATE WITH INDIVIDUALS SUFFERING FROM ALCOHOL INTOXICATION
[patent_app_type] => utility
[patent_app_number] => 17/242115
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242115
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242115 | COMPOSITION, AND METHOD OF USING THE COMPOSITION, EFFECTIVE FOR MINIMIZING THE HARMFUL EFFECTS ASSOCIATE WITH INDIVIDUALS SUFFERING FROM ALCOHOL INTOXICATION | Apr 26, 2021 | Abandoned |
Array
(
[id] => 16990122
[patent_doc_number] => 20210228542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => COMPOSITION AND METHOD FOR RAPIDLY INDUCING AN ENDOGENOUS KETOSIS
[patent_app_type] => utility
[patent_app_number] => 17/233007
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233007
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233007 | Composition and method for rapidly inducing an endogenous ketosis | Apr 15, 2021 | Issued |
Array
(
[id] => 17546543
[patent_doc_number] => 20220117884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => Methods and Compostitions for Enhancing the Viability of Microneedle Pores
[patent_app_type] => utility
[patent_app_number] => 17/228941
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10183
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228941
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228941 | Methods and Compostitions for Enhancing the Viability of Microneedle Pores | Apr 12, 2021 | Abandoned |
Array
(
[id] => 16976055
[patent_doc_number] => 20210220292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => CANNABINOID AND ANESTHETIC COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/226134
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17226134
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/226134 | CANNABINOID AND ANESTHETIC COMPOSITIONS AND METHODS | Apr 8, 2021 | Abandoned |
Array
(
[id] => 17609655
[patent_doc_number] => 20220151934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => RAPIDLY INFUSING PLATFORM AND COMPOSITIONS FOR THERAPEUTIC TREATMENT IN HUMANS
[patent_app_type] => utility
[patent_app_number] => 17/225738
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225738
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/225738 | Rapidly infusing platform and compositions for therapeutic treatment in humans | Apr 7, 2021 | Issued |
Array
(
[id] => 17213090
[patent_doc_number] => 20210346426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => COMPOSITION AND METHOD FOR THE TREATMENT OF COVID-19
[patent_app_type] => utility
[patent_app_number] => 17/225053
[patent_app_country] => US
[patent_app_date] => 2021-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225053
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/225053 | COMPOSITION AND METHOD FOR THE TREATMENT OF COVID-19 | Apr 6, 2021 | Abandoned |
Array
(
[id] => 17911336
[patent_doc_number] => 20220313731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => METHOD OF TREATING ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/214377
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214377
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/214377 | METHOD OF TREATING ALZHEIMER'S DISEASE | Mar 25, 2021 | Pending |
Array
(
[id] => 17472372
[patent_doc_number] => 20220079876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/210719
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210719
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/210719 | OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR | Mar 23, 2021 | Abandoned |
Array
(
[id] => 18636384
[patent_doc_number] => 11760971
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Modified biological control agents and their uses
[patent_app_type] => utility
[patent_app_number] => 17/206484
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12069
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206484
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/206484 | Modified biological control agents and their uses | Mar 18, 2021 | Issued |
Array
(
[id] => 17368235
[patent_doc_number] => 20220023287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => TREATMENT OF HEPATITIS DELTA VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/197687
[patent_app_country] => US
[patent_app_date] => 2021-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17197687
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/197687 | TREATMENT OF HEPATITIS DELTA VIRUS INFECTION | Mar 9, 2021 | Abandoned |
Array
(
[id] => 16998450
[patent_doc_number] => 11077232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Methods and polymer compositions for treating retinal detachment and other ocular disorders
[patent_app_type] => utility
[patent_app_number] => 17/191942
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16093
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191942
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191942 | Methods and polymer compositions for treating retinal detachment and other ocular disorders | Mar 3, 2021 | Issued |
Array
(
[id] => 17355336
[patent_doc_number] => 20220016132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
[patent_app_type] => utility
[patent_app_number] => 17/181781
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17181781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/181781 | BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES | Feb 21, 2021 | Pending |
Array
(
[id] => 17035092
[patent_doc_number] => 20210252050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => ANTI-INFLAMMATORY, DISINFECTING AND ACCELERATED HEALING GEL FOR WOUNDS AND LESIONS
[patent_app_type] => utility
[patent_app_number] => 17/155748
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155748
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/155748 | ANTI-INFLAMMATORY, DISINFECTING AND ACCELERATED HEALING GEL FOR WOUNDS AND LESIONS | Jan 21, 2021 | Abandoned |
Array
(
[id] => 16776434
[patent_doc_number] => 20210113511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF ACNE
[patent_app_type] => utility
[patent_app_number] => 17/137883
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137883
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/137883 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ACNE | Dec 29, 2020 | Pending |